Idexx Laboratories (IDXX) Change in Receivables (2009 - 2026)

Idexx Laboratories (IDXX) has reported Change in Receivables for 18 consecutive years, with $56.8 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Receivables rose 25.57% year-over-year to $56.8 million; the TTM figure through Mar 2026 stood at $80.3 million (up 308.0% YoY), while the FY2025 annual figure was $68.7 million, up 143.01% from the prior year.
• Change in Receivables came in at $56.8 million for Q1 2026 at Idexx Laboratories, up from -$13.9 million in the prior quarter.
• The five-year high for Change in Receivables was $56.8 million in Q1 2026, with the low at -$27.8 million in Q4 2024.
• Average Change in Receivables over 5 years is $14.7 million, with a median of $16.3 million recorded in 2022.
• Across the five-year window, Change in Receivables soared 505.16% in 2022 and slumped 3953.5% in 2024, its largest moves.
• Year by year, Change in Receivables stood at $6.3 million in 2022, then plunged by 110.83% to -$686000.0 in 2023, then plunged by 3953.5% to -$27.8 million in 2024, then surged by 50.14% to -$13.9 million in 2025, then soared by 509.75% to $56.8 million in 2026.
• According to Business Quant data, Change in Receivables over the past three periods registered $56.8 million, -$13.9 million, and $7.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.